Titre:
  • Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.
Auteur:Bosly, André; Bron, Dominique; van Hoof, Achiel; De Bock, R; Berneman, Zwi Nisan; Ferrant, Augustin; Kaufman, L.; Dauwe, M; Verhoef, G
Informations sur la publication:Annals of hematology, 87, 4, page (277-283)
Statut de publication:Publié, 2008-04
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:CHOP regimen
Diffuse large B-cell lymphoma
Dose intensity
Non-Hodgkin's lymphoma
MeSH keywords:Adult
Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Bleomycin -- administration & dosage
Bleomycin -- pharmacokinetics
Combined Modality Therapy
Cyclophosphamide -- administration & dosage
Cyclophosphamide -- pharmacokinetics
Dose-Response Relationship, Drug
Doxorubicin -- administration & dosage
Doxorubicin -- pharmacokinetics
Follow-Up Studies
Granulocyte Colony-Stimulating Factor -- therapeutic use
Humans
Lymphoma -- classification
Lymphoma -- drug therapy
Lymphoma -- mortality
Lymphoma -- radiotherapy
Lymphoma, Large B-Cell, Diffuse -- drug therapy
Lymphoma, Large B-Cell, Diffuse -- mortality
Patient Selection
Prednisone -- administration & dosage
Prednisone -- pharmacokinetics
Retrospective Studies
Survival Analysis
Time Factors
Vindesine -- administration & dosage
Vindesine -- pharmacokinetics
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0939-5555
info:doi/10.1007/s00277-007-0399-y
info:scp/41249092380
info:pmid/17952688